Fig 1.
Flow chart of study participant enrollment.
Hr, isoniazid-resistant; TB, tuberculosis; H, isoniazid; R, rifampicin; E, ethambutol; Z, pyrazinamide; Fq, fluoroquinolone.
Table 1.
Baseline characteristics of 318 enrolled pulmonary tuberculosis patients with isoniazid-resistant rifampicin-susceptible strain stratified by different types of initial baseline regimens.
Table 2.
Treatment outcomes among 318 enrolled pulmonary tuberculosis patients with isoniazid-resistant rifampicin-susceptible strain.
Table 3.
Univariable logistic regression assessing factors associated with positive treatment outcomes.
Fig 2.
Forest plot of odds ratios of positive treatment outcome by additional fluoroquinolone use, stratified by initial baseline regimens.
H, isoniazid; R, rifampicin; E, ethambutol; Z, pyrazinamide; Fq, fluoroquinolone; OR, odds ratio; CI, confidence interval.
Table 4.
Multivariable logistic regression assessing factors associated with positive treatment outcomes.